LXEO R&D Expenses
Lexeo Therapeutics Inc · R&D Expenses
LXEO R&D Expenses
Latest reported$66.64Mperiod ending
LXEO TTM R&D Expenses ($49.16M → $66.64M)
TTM R&D Expenses
High-resolution chart · PNG
LXEO r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 66,635,000 | |
| 62,329,000 | |
| 63,797,000 | |
| 65,953,000 | |
| 73,681,000 | |
| 75,520,000 | |
| 74,091,000 | |
| 63,935,000 | |
| 57,758,000 | |
| 52,434,000 | |
| 53,130,000 | |
| 56,307,000 | |
| 54,423,000 | |
| 55,454,000 | |
| 49,162,371 |